News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
1. "5G: What You Need to Know About the Next Generation of Wireless Technology" 2. "AI and Machine Learning: What They Are and How They Are Changing Our Lives" 3. "The Internet of Things: How Connected Devices are Transforming Business" 4. "What is Blockchain and How is it Changing the Business World" 5. "The Rise of Big Data and How it is Changing Business Decision Making" 6. "The Impact of Automation and Robotics on the Global Economy" 7. "The Future of Digital Payments and Cryptocurrency" 8. "The Role of Artificial Intelligence in Cybersecurity" 9. "The Impact of Cloud Computing on Businesses" 10. "The Benefits of Augmented Reality and Virtual Reality in Business"
Models are indispensable. Reality is insanely complex. Mapping every possible interaction would be computationally impossible and utterly useless for understanding the world. Instead, we flatten things down to key causal variables and use them to help us make predictions and decisions. But models come in different shapes and sizes. Which model is useful depends on […]
Big tech’s recent embrace of nuclear power highlights a shared strategic challenge between AI firms and energy providers: managing time. As AI-driven data centers send electricity demand soaring, companies like Microsoft, Meta, and Amazon are investing directly in nuclear to ensure a stable, carbon-neutral power supply. Two core timing problems anchor this shift: energy providers struggle to predict when demand will justify massive infrastructure investments, while AI firms need suppliers to meet aggressive build timelines. The article argues that solving both requires rethinking time as a strategic asset. To predict market readiness, energy firms must get closer to customers—via partnerships and physical proximity—to reduce risk and align investment with real demand. To set enforceable deadlines, AI firms must take credible, financial stakes in supply chains, signaling commitment and urgency. The piece offers lessons for other industries: use tools like contracts, integration, and co-creation to align stakeholders; and treat timing not as a constraint, but as a strategic variable critical to delivering the future on schedule.
Surging homeowner demand and oversubscribed securitizations solidify Point’s position at the forefront of home equity investingPalo Alto, California, June 17, 2025 (GLOBE NEWSWIRE) -- Point, a leading home equity investment platform, proudly announces a significant milestone: funding its 15,000th homeowner. This achievement underscores Point's commitment to providing innovative financial solutions, enabling homeowners across the U.S. to access over $1.5 billion in home equity. "Reaching 15,000 funded homeowners is more than just a number; it's a testament to our mission of financial inclusivity," said Eddie Lim, CEO and cofounder of Point. "We've seen firsthand how accessing home equity can transform lives, whether it's eliminating or consolidating debt, funding education, or navigating financial hardships, without monthly payments. Our growth reflects homeowners' trust in us to help them achieve their financial goals." Since its inception, Point has revolutionized the way homeowners leverage their property's value through its flagship product, the Home Equity Investment (HEI). Unlike traditional loans, the HEI offers homeowners a lump sum in exchange for a share in their home's future appreciation, with no monthly payments and a 30-year term to settle the investment. This model has proven especially beneficial for those who might not qualify for conventional financing due to credit constraints or variable income streams. This milestone comes on the heels of Point’s most recent securitization, a $248 million rated transaction completed in partnership with funds managed by Blue Owl Capital. The deal was significantly oversubscribed, securing more than $2 billion in investor orders and marking Point’s fourth rated and largest securitization to date. The strong investor demand reflects the growing institutional appetite for Home Equity Investments and validates the performance and scalability of Point’s platform. These transactions not only provide capital to fund more homeowners but also demonstrate increasing confidence in HEIs as a maturing, mainstream asset class. About Point Point is the leading home equity platform making homeownership more valuable and accessible. Point’s flagship product, the Home Equity Investment (HEI), empowers homeowners to unlock their equity to eliminate debt, get through periods of financial hardship, and diversify their wealth – without adding to their monthly expenses. Point has worked with more than 15,000 homeowners, unlocking more than $1.5 billion in home equity. Point’s HEI enables investors to access a previously untapped asset class – owner-occupied residential real estate. Founded in 2015 by Eddie Lim, Eoin Matthews, and Alex Rampell, Point is backed by top investors, including Westcap, Andreessen Horowitz, Ribbit Capital, Greylock Partners, Bloomberg Beta, Blue Owl Capital, Alpaca VC, and Prudential. The company is headquartered in Palo Alto, CA. For more information, please visit www.point.com CONTACT: Amanda Woolley Point 3603191738 awoolley@point.com
. As always, Murphy’s video masterfully distils abstract economic concepts into clear, jargon-free explanations, making complex issues accessible to non-experts and relevant to everyday life. In so-called ‘modern’ macroeconomics—whether in the form of Dynamic Stochastic General Equilibrium (DSGE), the New Synthesis, New Classical, or 'New Keynesian’ models -- economic variables are treated as if they…
This regulatory milestone marks TISSIUM’s entry into the U.S. market and establishes the foundation of the TISSIUM polymer platform for atraumatic tissue repair Paris, France, Cambridge, USA, June 24, 2025 - TISSIUM, a MedTech company pioneering biomorphic programmable polymers for tissue reconstruction, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization for COAPTIUM® CONNECT with TISSIUM Light, a first-of-its-kind atraumatic sutureless solution for peripheral nerve repair. This authorization represents a pivotal regulatory milestone for TISSIUM, further validating its biopolymer platform and enabling U.S. commercialization of its first product. COAPTIUM® CONNECT is now the only FDA-authorized system designed for atraumatic sutureless nerve coaptation. Christophe Bancel, Co-Founder and CEO of TISSIUM said: “This FDA marketing authorization validates over a decade of scientific and clinical commitment to developing next-generation solutions in tissue reconstruction. COAPTIUM® CONNECT is the first demonstration of the transformative potential of our polymer platform and an important step in making atraumatic tissue repair available to patients.” Peripheral nerve injuries affect hundreds of thousands of patients annually and are typically repaired using microsurgical sutures. However, this approach presents limitations—including technical complexity, risk of additional trauma, and variable outcomes. COAPTIUM® CONNECT addresses these challenges by offering a reproducible, atraumatic sutureless alternative that preserves nerve integrity and simplifies the coaptation process1. In a recent clinical study on 12 patients with digital nerve injuries, COAPTIUM® CONNECT achieved 100% procedural success, defined as successful atraumatic sutureless coaptation using the polymer-assisted coaptation device, with all patients regaining full flexion and extension of the injured digit and reporting no pain 12 months after the procedure1. TISSIUM plans to initiate commercial rollout of COAPTIUM® CONNECT in the coming months. The COAPTIUM® CONNECT System leverages TISSIUM’s unique biopolymer platform, invented by Maria Pereira, Jeffrey Karp and Robert Langer at the MIT and Brigham & Women’s Hospital, using its bioresorbable light-activated surgical polymer and its 3D-printed polymer chamber. Maria Pereira, Co-Founder and Chief Innovation Officer, said: “This first product illustrates the technical versatility and the potential of the TISSIUM polymer platform, not only in peripheral nerve repair where other solutions are currently under development, but also in other surgical applications, such as atraumatic hernia repair and cardiovascular sealing.” *** About TISSIUM TISSIUM is a clinical and commercial stage MedTech company based in Paris, France, Cambridge, USA, and with a manufacturing site in Roncq, France. The company is pioneering a proprietary platform of fully biosynthetic, biomorphic, programmable, elastomeric polymers designed to address critical unmet needs in atraumatic tissue repair and tissue reconstruction. TISSIUM’s diversified pipeline includes seven products across three core verticals: sutureless nerve repair, atraumatic hernia repair, and cardiovascular sealants. Each solution is designed to optimize tissue repair through controlled and consistent procedures with specialized delivery and activation devices to maximize the performance and usability of its products. Founded in 2013, TISSIUM is built on breakthrough research and intellectual property originating from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women’s Hospital). For more information, please visit www.TISSIUM.com and follow us on LinkedIn: TISSIUM. *** Contacts Investor relationsRomain Attard – Chief Financial Officer rattard@tissium.com Press tissium@yourstorypr.com 1 A Sutureless Approach to Nerve Repair: Results from a Clinical Study in Digital Nerves, Randi Bindra, Journal of Hand Surgery, submitted 2025 Attachment 20250624 - TISSIUM_FDA DeNovo announcement
Garrett opens second innovation center in China to expand zero-emission R&D capabilitiesNew Wuhan lab prioritizes high-speed E-Powertrain systems for zero-emission applications Wuhan and Shanghai now form dual innovation hubs driving global collaboration WUHAN, China, June 26, 2025 (GLOBE NEWSWIRE) -- Garrett Motion Inc. (NASDAQ: GTX), a global leader in differentiated automotive technologies, today inaugurated its new Wuhan Innovation Center. Located within Garrett’s Wuhan Plant, the facility strengthens the company’s global and China-based zero-emission R&D footprint. As Garrett’s second innovation hub in China, it joins the Shanghai R&D Center to form a powerful “dual innovation engine” advancing motion in every form - from turbocharging leadership to zero-emission differentiated solutions across mobility and beyond. “The launch of our Wuhan Innovation Center marks a bold step forward in Garrett’s electrification journey," said Olivier Rabiller, President and CEO of Garrett Motion. "We are scaling our zero-emission capabilities where innovation is happening fastest—right here in China. This new hub strengthens our global technology engine and reinforces Garrett’s position as a differentiated technology provider in decarbonizing mobility and industry alike.” Mr. Li Feng, Chief Inspector of Wuhan East Lake High-tech Development Zone, attended the event and commented: “Automotive is one of Wuhan’s most dynamic industries, and we are pleased to see a global leader like Garrett deepen its presence here. The new Innovation Center marks an important step in Wuhan’s ongoing efforts to promote high-level openness and industrial development, and it strengthens our role as a national hub for science and technology.” 20 Years of Innovation in China: Accelerating Local R&D Expansion For 70 years, Garrett has advanced mobility technologies around the world, developing numerous industry-first technologies—from variable geometry turbines to air-bearing compressors for hydrogen fuel cells. In China, Garrett has built two decades of innovation since establishing its Shanghai R&D Center in 2005. The company has developed and industrialized a range of China-specific solutions such as: Gasoline Variable Nozzle Turbine (VNT) turbos to boost thermal efficiency, improving fuel efficiency.Wastegate turbochargers optimized for PHEVs (Plug-in Hybrid Electric Vehicles) and REEVs (Range-Extended Electric Vehicles) increasing range while optimizing CO2 emissions. Hydrogen fuel cell compressors serving both LV (Light Vehicle) and CV (Commercial Vehicle) customers. These innovations not only support Chinese OEMs locally but also help them expand business globally. With the launch of the Wuhan Innovation Center, Garrett enters a new phase—reinforcing long-term investment in China and expanding its innovation footprint in zero-emission mobility and beyond. Driving Zero-Emission Innovation Across Mobility and Beyond As electrification accelerates across the automotive sector, Garrett is scaling its portfolio of zero-emission technologies. Leveraging core strengths in high-speed motors, power electronics, controls software, oil-less bearings, and system integration, Garrett is advancing solutions including: 3-in-1 E-Powertrain systems;E-Cooling refrigerant compressors;Established fuel cell compressors. The company’s high-speed, high-power density E-Powertrain integrates an electric motor, inverter, and gearbox—reducing system size and weight by up to 40%. Featuring speeds up to 35,000 rpm and high-efficiency inverters, the system cuts use of critical materials by ~30%. It supports 400V and 800V vehicle architectures. First unveiled at the 2025 Shanghai Auto Show, the E-Powertrain has already secured its first series production order with HanDe for heavy-duty trucks—marking a key commercial milestone. The Wuhan Innovation Center is focused on accelerating development of these zero-emission systems. Inverter testing is already operational, with further expansions planned to cover full power electronics validation—including compressors for fuel cells and e-cooling systems—supporting both automotive and industrial decarbonization. A Strategic Hub for Innovation and Collaboration "The Wuhan Innovation Center is a clear embodiment of Garrett's 'East for East' strategy," said Jessica Zhang, Vice President and General Manager, Garrett China. "By integrating R&D and manufacturing capabilities in China, we are accelerating the commercialization of zero-emission technologies—from prototype through testing to production." The new Center also serves as a collaboration platform—attracting cross-disciplinary talent and forging partnerships with academic institutions, research bodies, and industry players to fuel the next wave of innovation. About Garrett Motion Inc. A differentiated technology leader, Garrett Motion has a 70-year history of innovation in the automotive sector (cars, trucks) and beyond (off-highway equipment, marine, power generators). Its expertise in turbocharging has enabled significant reductions in engine size, fuel consumption, and CO2 emissions. Garrett is expanding its positive impact by developing differentiated technology solutions for Zero Emission Vehicles, such as fuel cell compressors for hydrogen fuel cell vehicles, as well as electric propulsion and thermal management systems for battery electric vehicles. Garrett has now six R&D centers, 13 manufacturing facilities and a team of more than 9,000 employees in more than 20 countries. Its mission is to enable the transportation industry to advance motion through unique, differentiated innovation. For more information, please visit www.garrettmotion.com. About Garrett Motion China Garrett established its presence in China in 1994 and was among the first global companies to introduce turbocharging technology into the country. Headquartered in Shanghai, Garrett has two world-class, advanced manufacturing facilities in Shanghai and Wuhan, as well as 2 innovation centers. The company employs more than 1,000 people, including a China R&D team of over 200 specialists with end-to-end engineering and service capabilities. Garrett boasts lasting partnerships with more than 30 global and Chinese automakers. It offers a comprehensive portfolio of turbocharging technology for gasoline, diesel, natural gas, hybrid and zero emission technology for battery electric vehicles in automotive sector and beyond. CONTACTS: Global MediaInvestor RelationsAmanda JonesCyril Grandjeanamanda.jones@garrettmotion.cominvestorrelations@garrettmotion.com Cell. +41 79 601 07 87Cell. +1 734 392 5504 CHINA MediaYang Huyang.hu1@garrettmotion.com Cell. +86 189 1760 6610 A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6c4e0510-f3ac-4f3a-bbdb-000ee34f97ee